Details
| Stereochemistry | MIXED |
| Molecular Formula | C7H15NS2 |
| Molecular Weight | 177.331 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1SC(C)NC(C)S1
InChI
InChIKey=BHTMBVSWSZTUBT-UHFFFAOYSA-N
InChI=1S/C7H15NS2/c1-4-7-9-5(2)8-6(3)10-7/h5-8H,4H2,1-3H3
| Molecular Formula | C7H15NS2 |
| Molecular Weight | 177.331 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:28:15 GMT 2023
by
admin
on
Sat Dec 16 14:28:15 GMT 2023
|
| Record UNII |
R63L8P9C14
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
R63L8P9C14
Created by
admin on Sat Dec 16 14:28:15 GMT 2023 , Edited by admin on Sat Dec 16 14:28:15 GMT 2023
|
PRIMARY | |||
|
529054
Created by
admin on Sat Dec 16 14:28:15 GMT 2023 , Edited by admin on Sat Dec 16 14:28:15 GMT 2023
|
PRIMARY | |||
|
2093
Created by
admin on Sat Dec 16 14:28:15 GMT 2023 , Edited by admin on Sat Dec 16 14:28:15 GMT 2023
|
PRIMARY | |||
|
DTXSID401020037
Created by
admin on Sat Dec 16 14:28:15 GMT 2023 , Edited by admin on Sat Dec 16 14:28:15 GMT 2023
|
PRIMARY | |||
|
54717-14-5
Created by
admin on Sat Dec 16 14:28:15 GMT 2023 , Edited by admin on Sat Dec 16 14:28:15 GMT 2023
|
PRIMARY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Volume of Distribution | PHARMACOKINETIC |
|
MALE PHARMACOKINETIC |
|||
| Tmax | PHARMACOKINETIC |
|
ORAL, IMMEDIATE-RELEASE TABLET (HEPATIC IMPAIRMENT) PHARMACOKINETIC PHARMACOKINETIC |
|||
| Route of Elimination | PHARMACOKINETIC |
|
EXCRETED UNCHANGED, RENAL PHARMACOKINETIC |
|||
| MAXIMUM TOLERATED DOSE | TOXICITY |
|
IMMEDIATE-RELEASE TABLET |
|||
| ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
EXTENDED-RELEASE TABLET PHARMACOKINETIC |
|||
| Tmax | PHARMACOKINETIC |
|
EFFECT OF FOOD PHARMACOKINETIC |
|||
| Route of Elimination | PHARMACOKINETIC |
|
PERCENT EXCRETED UNCHANGED PHARMACOKINETIC |
|||
| PROTEIN BINDING | PHARMACOKINETIC |
|
||||
| Biological Half-life | PHARMACOKINETIC |
|
IV, RENAL IMPAIRMENT (CrCL LESS THAN 30 mL/min) PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC |